|
1.
|
Moe RE and Anderson BO: Androgens and
androgen receptors: a clinically neglected sector in breast cancer
biology. J Surg Oncol. 95:437–439. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Birrell SN, Hall RE and Tilley WD: Role of
the androgen receptor in human breast cancer. J Mammary Gland Biol
Neoplasia. 3:95–103. 1998.PubMed/NCBI
|
|
3.
|
Somboonporn W and Davis SR: Testosterone
effects on the breast: implications for testosterone therapy for
women. Endocr Rev. 25:374–388. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Labrie F, Luu-The V, Labrie C, Bélanger A,
Simard J, Lin SX and Pelletier G: Endocrine and intracrine sources
of androgens in women: inhibition of breast cancer and other roles
of androgens and their precursor dehydroepiandrosterone. Endocr
Rev. 24:152–182. 2003.
|
|
5.
|
Yeh S, Hu YC, Wang PH, Xie C, Xu Q, Tsai
MY, Dong Z, Wang RS, Lee TH and Chang C: Abnormal mammary gland
development and growth retardation in female mice and MCF7 breast
cancer cells lacking androgen receptor. J Exp Med. 198:1899–1908.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Agrawal AK, Jeleń M, Grzebieniak Z,
Zukrowski P, Rudnicki J and Nienartowicz E: Androgen receptors as a
prognostic and predictive factor in breast cancer. Folia Histochem
Cytobiol. 46:269–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Niemeier LA, Dabbs DJ, Beriwal S, Striebel
JM and Bhargava R: Androgen receptor in breast cancer: expression
in estrogen receptor-positive tumors and in estrogen
receptor-negative tumors with apocrine differentiation. Mod Pathol.
232:205–212. 2010. View Article : Google Scholar
|
|
8.
|
Lanzino M, Sisci D, Morelli C, Garofalo C,
Catalano S, Casaburi I, Capparelli C, Giordano C, Giordano F,
Maggiolini M and Andò S: Inhibition of cyclin D1 expression by
androgen receptor in breast cancer cells - identification of a
novel androgen response element. Nucleic Acids Res. 38:5351–5365.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Gonzalez LO, Corte MD, Vazquez J, Junquera
S, Sanchez R, Alvarez AC, Rodriguez JC, Lamelas ML and Vizoso FJ:
Androgen receptor expression in breast cancer: relationship with
clinicopathological characteristics of the tumors, prognosis, and
expression of metalloproteases and their inhibitors. BMC Cancer.
8:1492008. View Article : Google Scholar
|
|
10.
|
Castellano I, Allia E, Accortanzo V,
Vandone AM, Chiusa L, Arisio R, Durando A, Donadio M, Bussolati G,
Coates AS, Viale G and Sapino A: Androgen receptor expression is a
significant prognostic factor in estrogen receptor positive breast
cancers. Breast Cancer Res Treat. 124:607–617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Agoff SN, Swanson PE, Linden H, Hawes SE
and Lawton TJ: Androgen receptor expression in estrogen
receptor-negative breast cancer. Immunohistochemical, clinical, and
prognostic associations. Am J Clin Pathol. 120:725–731. 2003.
View Article : Google Scholar
|
|
12.
|
Nahleh Z: Androgen receptor as a target
for the treatment of hormone receptor negative breast cancer: an
unchartered territory. Future Oncol. 4:15–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yu Q, Niu Y, Liu N, Zhang JZ, Liu TJ,
Zhang RJ, Wang SL, Ding XM and Xiao XQ: Expression of androgen
receptor in breast cancer and its significance as a prognostic
factor. Ann Oncol. 226:1288–1294. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Collins LC, Cole KS, Marotti JD, Hu R,
Schnitt SJ and Tamimi RM: Androgen receptor expression in breast
cancer in relation to molecular phenotype: results from the Nurses’
Health Study. Mod Pathol. 24:924–931. 2011.PubMed/NCBI
|
|
15.
|
Baniahmad A: Nuclear hormone receptor
co-repressors. J Steroid Biochem Mol Biol. 93:89–97. 2005.
View Article : Google Scholar
|
|
16.
|
Dehm SM and Tindall DJ: Molecular
regulation of androgen action in prostate cancer. J Cell Biochem.
99:333–344. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Nicolás Díaz-Chico B, Germán Rodríguez F,
González A, Ramírez R, Bilbao C, Cabrera de León A, Aguirre Jaime
A, Chirino R, Navarro D and Díaz-Chico JC: Androgens and androgen
receptors in breast cancer. J Steroid Biochem Mol Biol. 105:1–15.
2007.
|
|
18.
|
Shi XB, Tepper CG and De Vere White RW:
Cancerous miRNAs and their regulation. Cell Cycle. 7:1529–1538.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu
M, Tepper CG, Evans CP, Kung HJ and De Vere White RW: An
androgen-regulated miRNA suppresses Bak1 expression and induces
androgen-independent growth of prostate cancer cells. Proc Natl
Acad Sci USA. 104:19983–19988. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Takayama K, Tsutsumi S, Katayama S,
Okayama T, Horie-Inoue K, Ikeda K, Urano T, Kawazu C, Hasegawa A,
Ikeo K, Gojyobori T, Ouchi Y, Hayashizaki Y, Aburatani H and Inoue
S: Integration of cap analysis of gene expression and chromatin
immunoprecipitation analysis on array reveals genome-wide androgen
receptor signaling in prostate cancer cells. Oncogene. 30:619–630.
2011. View Article : Google Scholar
|
|
21.
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Büssing I, Slack FJ and Grosshans H: Let-7
microRNAs in development, stem cells and cancer. Trends Mol Med.
14:400–409. 2008.
|
|
23.
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs, key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Hall RE, Birrell SN, Tilley WD and
Sutherland RL: MDA-MB-453, an androgen-responsive human breast
carcinoma cell line with high level androgen receptor expression.
Eur J Cancer. 30A:484–490. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Yeap BB, Krueger RG and Leedman PJ:
Differential posttranscriptional regulation of androgen receptor
gene expression by androgen in prostate and breast cancer cells.
Endocrinology. 140:3282–3291. 1999.PubMed/NCBI
|
|
28.
|
Subik K, Lee JF, Baxter L, Strzepek T,
Costello D, Crowley P, Xing L, Hung MC, Bonfiglio T, Hicks DG and
Tang P: The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67
and AR by immunohistochemical analysis in breast cancer cell lines.
Breast Cancer (Auckl). 4:35–41. 2010.PubMed/NCBI
|
|
29.
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao
KQ, Livak KJ and Guegler KJ: Real-time quantification of microRNAs
by stem-loop RT-PCR. Nucleic Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Louie MC, Yang HQ, Ma AH, Xu W, Zou JX,
Kung HJ and Chen HW: Androgen-induced recruitment of RNA polymerase
II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad
Sci USA. 100:2226–2230. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Seifer DB, MacLaughlin DT, Penzias AS,
Behrman HR, Asmundson L, Donahoe PK, Haning RV Jr and Flynn SD:
Gonadotropin-releasing hormone agonist-induced differences in
granulosa cell cycle kinetics are associated with alterations in
follicular fluid müllerian-inhibiting substance and androgen
content. J Clin Endocrinol Metab. 76:711–714. 1993.PubMed/NCBI
|
|
32.
|
Harvey JM, Clark GM, Osborne CK and Allred
DC: Estrogen receptor status by immunohistochemistry is superior to
the ligand-binding assay for predicting response to adjuvant
endocrine therapy in breast cancer. J Clin Oncol. 17:1474–1481.
1999.
|
|
33.
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
Mitsudomi T and Takahashi T: Reduced expression of the let-7
microRNAs in human lung cancers in association with shortened
postoperative survival. Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Dahiya N, Sherman-Baust CA, Wang TL,
Davidson B, Shih IeM, Zhang Y, Wood W III, Becker KG and Morin PJ:
MicroRNA expression and identification of putative miRNA targets in
ovarian cancer. PLoS One. 3:e24362008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
O’Hara AJ, Wang L, Dezube BJ, Harrington
WJ Jr, Damania B and Dittmer DP: Tumor suppressor microRNAs are
underrep-resented in primary effusion lymphoma and Kaposi sarcoma.
Blood. 113:5938–5941. 2009.PubMed/NCBI
|
|
36.
|
Engels BM and Hutvagner G: Principles and
effects of microRNA-mediated post-transcriptional gene regulation.
Oncogene. 25:6163–6169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Sampson VB, Rong NH, Han J, Yang Q, Aris
V, Soteropoulos P, Petrelli NJ, Dunn SP and Krueger LJ: MicroRNA
let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt
lymphoma cells. Cancer Res. 67:9762–9770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
He XY, Chen JX, Zhang Z, Li CL, Peng QL
and Peng HM: The let-7a microRNA protects from growth of lung
carcinomaby suppression of k-Ras and c-Myc in nude mice. J Cancer
Res Clin Oncol. 136:1023–1028. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Akao Y, Nakagawa Y and Naoe T: let-7
microRNA functions as a potential growth suppressor in human colon
cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Lee RC, Feinbaum RL, Ambros V and The C:
Elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Ruby JG, Jan C, Player C, Axtell MJ, Lee
W, Nusbaum C, Ge H and Bartel DP: Large-scale sequencing reveals
21U-RNAs and additional microRNAs and endogenous siRNAs in C.
elegans. Cell. 127:1193–1207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Sempere LF, Christensen M, Silahtaroglu A,
Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S and Cole CN:
Altered microRNA expression confined to specific epithelial cell
subpopulations in breast cancer. Cancer Res. 67:11612–11620. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong
C, Huang Y, Hu X, Su F, Lieberman J and Song E: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
